Glucose reduces the anticonvulsant effects of the ketogenic diet in EL mice > 2014

본문 바로가기

접속자집계

오늘
1,618
전체
2,137,812
TEL:02-3789-7891
사이트 내 전체검색

Home >
2014

Glucose reduces the anticonvulsant effects of the ketogenic diet in EL…

작성자 채식영양
작성일 14-01-01 00:00 | 조회 0 | 댓글 0

본문

JG. Mantis, JJ. Meidenbauer, NC. Zimick, NA. Centeno and TN. Seyfried (2014). Glucose reduces the anticonvulsant effects of the ketogenic diet in EL mice. Epilepsy research, 108(7), 1137-44. https://doi.org/10.1016/j.eplepsyres.2014.05.010

PubMed 24938543


[Abstract]
The ketogenic diet (KD) is known to be anticonvulsant and anti-epileptogenic. While the mechanism behind this therapeutic benefit is unclear, a reduction of circulating glucose levels through calorie restriction (CR) has been implicated. Foods or drinks that elevate blood glucose are known to compromise the therapeutic benefit of the KD in some children with epilepsy. We therefore evaluated the effect of a calorie restricted KD (KD-R) with supplementation of glucose in the drinking water of EL mice, a natural model of idiopathic generalized epilepsy, prior to seizure testing to assess the effect of glucose on seizure generation. Mice were fed either a standard diet or the KD unrestricted (SD-UR and KD-UR, respectively), or the KD restricted (KD-R). d-Glucose (25 mM) was supplemented in the drinking water of KD-R fed mice for 0.5h or for 2.5h prior to seizure testing. Each restricted mouse served as its own body weight control to achieve a 15-18% body weight reduction. Seizure susceptibility, body weights, and plasma glucose and β-hydroxybutyrate levels were measured over a nine-week treatment period. Body weights and glucose levels remained high over the testing period in both the SD-UR and the KD-UR groups, but were significantly reduced in all R-fed groups. A significant increase in β-hydroxybutyrate levels was observed in all KD groups. Seizure susceptibility remained highest in the SD-UR group, was slightly reduced in the KD-UR group, and was significantly reduced after three weeks in all R-fed groups. Supplementation of glucose prior to seizure testing resulted in a decrease of seizure threshold for R-fed mice, but did not alter bodyweight or circulating glucose levels. The KD has both an anticonvulsant and antiepileptogenic effect in EL mice. Here we confirm that CR enhances the anticonvulsant action of the KD in EL mice. Additionally, we show for the first time that supplementation of glucose decreases the anticonvulsant action of the KD, which further supports the hypothesis that CR works through transitioning metabolism from glucose to ketone utilization for energy.

0
  • 페이스북으로 보내기
  • 트위터로 보내기
  • 구글플러스로 보내기

댓글목록 0

등록된 댓글이 없습니다.

Total 125
2014 목록
번호 제목 글쓴이 날짜 조회 추천
80 텍스트 Low carbohydrate diet score does not predict metabolic syndr… 링크 채식영양 01-01 1 0
79 텍스트 High-fat, low-carbohydrate diet promotes arrhythmic death an… 링크 채식영양 01-01 1 0
열람중 텍스트 Glucose reduces the anticonvulsant effects of the ketogenic … 링크 채식영양 01-01 1 0
77 텍스트 The use of low-carbohydrate diet in type 2 diabetes - benefi… 링크 채식영양 01-01 1 0
76 텍스트 Retrospective study on the efficacy of a low-carbohydrate di… 링크 채식영양 01-01 1 0
75 텍스트 Low carbohydrate diets not always benign 링크 채식영양 01-01 1 0
74 텍스트 The effects of a ketogenic diet on exercise metabolism and p… 링크 채식영양 01-01 1 0
73 텍스트 Epilepsy Treatment Simplified through Mobile Ketogenic Diet … 링크 채식영양 01-01 1 0
72 텍스트 Long-term effects of a very low-carbohydrate weight loss die… 링크 채식영양 01-01 1 0
71 텍스트 Low carbohydrate versus isoenergetic balanced diets for redu… 링크 채식영양 01-01 1 0
70 텍스트 Ketogenic dietary therapies for adults with epilepsy: feasib… 링크 채식영양 01-01 1 0
69 텍스트 Ketogenic diet in patients with Lennox-Gastaut syndrome 링크 채식영양 01-01 0 0
68 텍스트 The ketogenic diet modifies social and metabolic alterations… 링크 채식영양 01-01 1 0
67 텍스트 High-protein-low-carbohydrate diet: deleterious metabolic an… 링크 채식영양 01-01 1 0
66 텍스트 Ketone strong: emerging evidence for a therapeutic role of k… 링크 채식영양 01-01 1 0
게시물 검색

한국채식정보. 대표:이광조ㅣsoypaper@hanmail.netㅣ대표전화: 02-3789-7891ㅣ서울시 용산구 갈월동 56-5. 일심빌딩 203호